Home Categories API Torsemide
A7821912

Torsemide , ≥98%(HPLC) , 56211-40-6

Synonym(s):
Demadex;N-[[(1-Methylethyl)amino]carbonyl]-4-[(3-methylphenyl)amino]-3-pyridinesulfonamide

CAS NO.:56211-40-6

Empirical Formula: C16H20N4O3S

Molecular Weight: 348.42

MDL number: MFCD00866166

EINECS: 637-197-3

Pack Size Price Stock Quantity
1G RMB36.00 In Stock
5G RMB97.60 In Stock
25G RMB352.80 In Stock
100G RMB1062.40 In Stock
others     Enquire
Update time: 2022-07-08

PRODUCT Properties

Melting point: 163-164°C
Density  1.283±0.06 g/cm3(Predicted)
storage temp.  Keep in dark place,Inert atmosphere,Room temperature
solubility  DMSO: soluble18mg/mL
pka 6.44(at 25℃)
form  solid
color  White
Water Solubility  Soluble
Merck  14,9552
BCS Class 1
InChIKey NGBFQHCMQULJNZ-UHFFFAOYSA-N
CAS DataBase Reference 56211-40-6(CAS DataBase Reference)
EPA Substance Registry System 3-Pyridinesulfonamide, N-[[(1-methylethyl)amino]carbonyl]-4-[(3-methylphenyl)amino]- (56211-40-6)

Description and Uses

Torasemide is a novel loop diuretic launched in 1993 after a 12-year gap from the last diuretic introduction. It is indicated for the treatment of hypertension and edema associated with chronic congestive heart failure, renal disease and hepatic cirrhosis. Torasemide exerts its major diuretic activity on the thick ascending limb of the Henle's loop to promote rapid and marked excretion of water, Na+, Cl-, and to a lesser extent,K+ and Ca2+. Compared with other loop diuretics such as furosemide, torasemide has a stronger antihypertensive action, a higher bioavailability, a longer duration of action that is independent of the renal function, and has no side effects such as paradoxical antidiuresis. The mechanism of its vasodilating effect has been suggested to result from, at least in part, the competitive antagonism of the thromboxane A2 receptor.

Torasemide is a loop diuretic. Diuretics have been abused as performance-enhancing drugs and masking agents in doping in sports. Use of torsemide is effective for the treatment of edema associated with chronic renal failure. The pharmacology of torasemide is similar to that of frusemide,though torasemide has a longer duration of action with a plasma half-life of approximately 3.5 hours. It also causes a less marked loss of potassiumand calcium.

Safety

Symbol(GHS) 
GHS07,GHS08
Signal word  Warning
Hazard statements  H319-H361fd
Precautionary statements  P201-P202-P264-P280-P305+P351+P338-P308+P313
Hazard Codes  Xi
Risk Statements  36-36/37/38
Safety Statements  26-37/39
WGK Germany  2
RTECS  UT7938000
HS Code  2935904000

RELATED PRODUCTS